Nobody downloaded yet

The of GlaxoSmithKline - Case Study Example

Comments (0) Cite this document
Summary
This study attempts to analyze the problems that have a risen in the blockbuster model of GlaxoSmithKline and how this company has attempted to diversify itself as a means of maintaining its high-profit levels. The study covers patent challenges, shape of the pipeline, as well as share prices.  …
Download full paperFile format: .doc, available for editing
GRAB THE BEST PAPER92.5% of users find it useful
The Case of GlaxoSmithKline
Read TextPreview

Extract of sample "The of GlaxoSmithKline"

Download file to see previous pages While the blockbuster strategy at GSK has been so successful in the past, it is nearing a period where it is more likely than not to become obsolete. This is as a result of a diverse number of challenges which have made blockbusters less profitable when compared to the past few decades. Among these challenges is the decline in R&D productivity where only a single compound out of nearly 13 discovered enters the market after clinical trials have been carried out and this is a big blow to pharmaceutical companies such as GSK. Moreover, because of the need to make the public aware of newly discovered drugs that enter the market, it is essential for companies to commercialize it. This takes increased funding and creates a situation where recent years have seen an increase in the costs of commercialisation for GSK in such a way that the processes of discovering, developing and launching new products have increased substantially. In addition, in recent years, patents to blockbusters have increasingly been challenged not only by smaller pharmaceutical companies but also by governments and this has created a situation where GSK has come face to face with serious limits to the revenue potential of its products. The shorter exclusivity periods that have come about as a result of competition has seen companies develop similar yet cheaper drugs than GSK’s blockbusters which have received the approval of numerous governments across the world. This situation has increased pressures on GSK’s patent protections. ...Download file to see next pagesRead More
Cite this document
  • APA
  • MLA
  • CHICAGO
(“The Case of GlaxoSmithKline Study Example | Topics and Well Written Essays - 2000 words”, n.d.)
The Case of GlaxoSmithKline Study Example | Topics and Well Written Essays - 2000 words. Retrieved from https://studentshare.org/business/1670198-the-case-of-glaxosmithkline
(The Case of GlaxoSmithKline Study Example | Topics and Well Written Essays - 2000 Words)
The Case of GlaxoSmithKline Study Example | Topics and Well Written Essays - 2000 Words. https://studentshare.org/business/1670198-the-case-of-glaxosmithkline.
“The Case of GlaxoSmithKline Study Example | Topics and Well Written Essays - 2000 Words”, n.d. https://studentshare.org/business/1670198-the-case-of-glaxosmithkline.
  • Cited: 0 times
Comments (0)
Click to create a comment or rate a document

CHECK THESE SAMPLES OF The Case of GlaxoSmithKline

(Ethics and Communication) Illinois among states to settle with GlaxoSmithKline

...?This article discusses the key aspects of a vital settlement that was reached between GlaxoSmithKLine with 37 s for selling prescribed antidepressant from its Puerto Rico factory subsidiary. This particular settlement divided the money between District of Columbia and other states. The case was headed by Oregon and Illinois because they company violated the protection laws which resulted in a $750 million in criminal and civil settlements. The root cause was the fact that GlaxoSmithKline contaminated two main ingredients in the antidepressant in the ointment they produced. Although the two main ingredients: Kytril and Bactroban were not fully contaminated, the tablets possessed not a...
1 Pages(250 words)Article

GlaxoSmithKline Plc and J Sainbury Plc: Accounting for Limited Companies

.... The use of ratio analysis does have its limitations because it does not consider other qualitative factors that may affect the financial results of a company such as a pending lawsuit. This report is going to compare two public companies based in the United Kingdom. Ratio analysis is going to be the primary tool to compare the financial results of both companies. The two companies that are going to be compared are GlaxoSmithKline Plc and J Sainbury Plc. An inherent limitation of the use of ratio analysis to compare the results of these two companies is that the two companies participate in different industries. Different industries on many occasions have different expectations and industry standards, thus a ratio that...
8 Pages(2000 words)Coursework

Separation Management in GlaxoSmithkline

...05-06-2007 Separation Management in GlaxoSmithkline GlaxoSmithkline (GSK) is one of the biggest pharmaceutical company having corporate headquarter in the UK and with operations based in US. It has been estimated that GSK have almost 7% of the world's pharmaceutical market share. It is a research based strong pharmaceutical company. GSK employees over 1,00,000 people in 116 countries. GSK turnover at the end of 2006 was $23.2 billion, which is 9% up from the previous year (Annual report, 2006). GSK have over 15,000 people working as research team to discover new medicines. Company have a challenging and inspiring mission to improve the quality of human life by enabling people to do more, feel better and...
9 Pages(2250 words)Case Study

KM at GlaxoSmithKline and McKinsey & Co

...KM at GlaxoSmithKline and McKinsey & Co. This paper discusses the knowledge management (KM) practices at two global companies that are acknowledged to be leaders in their respective fields: the pharmaceutical giant GlaxoSmithKline plc (GSK) and the management consulting firm McKinsey & Co. The paper has three parts. First, we provide a brief background on each company, highlighting the strategic importance of KM in the light of current global challenges and developments. Second, we identify and analyse each company's KM initiatives and assess the relevance of these efforts to each company's communities and how it contributes to their competitive advantage. Third, we compare these initiatives and...
11 Pages(2750 words)Essay

Impact of Sarbanes Oxley Act, 2002 on GlaxoSmithKline UK

...Impact of Sarbanes Oxley Act, 2002 on GlaxoSmithKline UK What is Corporate Governance The term corporate governance basically covers the systems and processes which are established by the corporate entities for ensuring proper accountability. Corporate governance ensures the establishment of relationships and their maintenance among both controlling and minority shareholders, the Board of Directors and other external stakeholders of the corporate entities. The basic principles on which the corporate governance functions include transparency, public accountability, fairness, and responsibility founded upon the concept of disclosure (Adam Dowdney). The objective of the observance of such principles is to encourage the...
10 Pages(2500 words)Essay

The GlaxoSmithKline Company

...the demands of the consumers. On the other hand in the domestic marketing mix the company has adapted the domestic promotional strategies and it does not have to lay a lot of emphasis on the language barriers as in the case of the international marketing promotional strategies. International pricing strategies GlaxoSmithKline Company has also adapted some international pricing strategies which has eased the international pricing difficulties. It puts into considerations factors such as the fixed and the variable costs, the company's objectives, the competition, the proposed company's positioning strategies as well as the target group and the willingness of the consumers to pay for the products. ...
12 Pages(3000 words)Case Study

International operation and competition study of GlaxoSmithKline plc

...International operation and competition study of GlaxoSmithKline plc. Contents Contents 2 0Introduction 4 1 Rational of Chosen industry and Company 5 1.2 Aims and Objectives 5 2.0 Competition Analysis 6 2.1 Porter’s Five Forces 7 2.2 PEST Analysis 9 2.3 Porter’s generic Strategy 11 3.0 Cross Cultural Management 12 3.1 Hoftede’s Five Dimension 13 Power Distance 14 Individualism 15 Masculinity 15 Uncertainty Avoidance 16 Long term Orientation 16 3.2 Trompenaar’s Seven Dimensions Model 16 Universalism Vs Pluralism 17 Individualism Vs Collectivism 17 Specific Vs Diffuse 17 Affectivity Vs Neutrality 18 Inner Directed Vs Outer Directed 18 Achieved Status Vs Ascribed Status 19 Sequential Time Vs Synchronic Time 19 4.0 CSR of...
20 Pages(5000 words)Essay

Corporate Social Responsibility-GlaxoSmithKline (GSK)

...Corporate Social Responsibility-GlaxoSmithKline (GSK) Corporate Social Responsibility-GlaxoSmithKline (GSK) Overview of the pharmaceutical market The pharmaceutical industry is very profitable. According to the IMS Health (2010), the size of the pharmaceutical market experienced a 6% growth 2006. The markets of U.S. and U.K. have the world’s largest pharmaceutical sales. Additionally, countries like Japan, Latin America, and China have recorded double-figure growth. Meanwhile, due to significant developments and global recession, disparate rates of evolution have grown in these countries. Industry analysts predict that this market will hit 1.1 trillion dollars by the end of this year. Pharmaceutical companies like GSK, Pfizer... societal...
1 Pages(250 words)Research Paper

Strategic Analysis report on pharmaceutical sector company - GlaxoSmithKline (gsk)

...that it can achieve future success. Reference List Anon, B. 2003, “About GlaxoSmithKline”. Nature, 422(6933), pp. 783-800 Anon, B. 2011. GlaxoSmithKline Case Study through Mergers & Acquisitions to Success. Datamonitor Plc, London. GlaxoSmithKline Plc. 2014, Annual Report 2013. Pureprint Group, Middlesex. Griffin, R. W. 2012, Fundamentals of Management. 6th ed. South-Western Cengage Learning, Mason, OH. Healy, P. M. & Palepu, K. G. 2010, Business Analysis and Valuation. Hampshire, Cengage. Kasapi, A. & Mihiotis, T. 2011, Management as Applied to New Products Penetration in the Competitive Environment of Pharmaceutical Industry. Interdisciplinary Journal of Research...
12 Pages(3000 words)Essay

Evaluating Bias in Research

...drug research. First, bias is seen as the panel to conduct research is selected. The panel may consist of workers of the companies or those that benefits from the companies as seen in the case of GlaxoSmithKline on Avandia (Whoriskey, 2012). The other assumption is that the effects of drugs are outweighed by the benefits the drugs to the patients. In the article, we note that the company disregards how Avandia is a risk to patient as it can lead to heart attacks (Whoriskey, 2012). The company assumes that benefits from the drug are more as compared to the harm it has on patients. As a result, the risk issues are not published in the final research. The other bias is seen as the drug companies dictate the...
1 Pages(250 words)Research Paper
sponsored ads
We use cookies to create the best experience for you. Keep on browsing if you are OK with that, or find out how to manage cookies.

Let us find you another Case Study on topic The Case of GlaxoSmithKline for FREE!

Contact Us